Skip Navigation



NDT Advance Access published online on October 25, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfi212
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/2/478    most recent
gfi212v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Marik, P. E.
Right arrow Articles by Starzl, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marik, P. E.
Right arrow Articles by Starzl, T. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received July 14, 2005
Accepted September 18, 2005

Original Articles

The course of type 1 hepato-renal syndrome post liver transplantation

Paul E. Marik 1*, Kelly Wood 2, and Thomas E. Starzl 3

1 Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA; Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA, USA
2 Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA
3 Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, USA

* To whom correspondence should be addressed.
Paul E. Marik, E-mail: paul.marik{at}jefferson.edu



  Abstract

Background. Hepato-renal syndrome (HRS) is a functional form of renal failure that occurs in patients with end-stage liver disease. Previously considered fatal without liver transplantation, treatment with vasoconstrictors and albumin has been demonstrated to improve renal function in patients with type 1 HRS. Liver transplantation is still considered the definitive treatment for HRS. However, the renal recovery rate and those factors that predict recovery post orthotopic liver transplantation have not been determined.

Methods. We reviewed the hospital course of 28 patients who met the International Ascites Club criteria for type I HRS and who underwent orthotopic liver transplant. The patients' demographic and pre- and post-operative laboratory data were recorded; patients were followed for 4 months post-transplantation or until death.

Results. The MELD score of the patients was 30±6. The mean duration of HRS prior to liver transplantation was 37±27 days. HRS resolved in 16 patients (58%). The mean time to resolution of HRS was 21±27 days, with a range of 4--110 days. Eight (50%) patients in whom the HRS resolved were undergoing pre-transplantation dialysis. The age of the recipients (49±10 vs 56±12; P = 0.05), the total bilirubin level on post-operative day 7 (6.0±4.3 vs 10.1±5.9 mg/dl; P = 0.04), alcoholic liver disease and the requirement for post-transplant dialysis were predictors of resolution of HRS by univariate analysis. Only alcoholic liver disease and post-transplant dialysis were independent (negative) predictors of resolution of HRS. Seven of the 12 (58%) patients who developed chronic renal insufficiency remained dialysis dependent. The pre-operative serum creatinine was non-significantly higher in the non-resolvers who remained dialysis dependent compared to those who did not require long-term dialysis (3.0±1.0 vs 2.3±0.4 mg/dl; P = 0.1) Four patients died; in three of these patients the HRS had resolved prior to their death.

Conclusion. HRS is not always cured by orthotopic liver transplant. Pre-transplantation dialysis or a long waiting period should not preclude transplantation in patients with HRS. HRS may not resolve in patients with alcoholic liver disease. We were unable to accurately define that group of patients with HRS who required long-term dialysis and could theoretically benefit from combined liver--kidney transplantation.

Keywords: cirrhosis; dialysis; hepato--renal syndrome; liver transplantation; renal failure.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
P. Gines and R. W. Schrier
Renal Failure in Cirrhosis
N. Engl. J. Med., September 24, 2009; 361(13): 1279 - 1290.
[Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
F. Salerno, A. Gerbes, P. Gines, F. Wong, and V. Arroyo
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
Postgrad. Med. J., December 1, 2008; 84(998): 662 - 670.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
F. Salerno, A. Gerbes, P. Gines, F. Wong, and V. Arroyo
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
Gut, September 1, 2007; 56(9): 1310 - 1318.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Schepke
Hepatorenal syndrome: current diagnostic and therapeutic concepts
Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_8): viii2 - viii4.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.